nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—BCHE—Cisplatin—testicular cancer	0.195	0.307	CbGbCtD
Triamcinolone—PTGS2—Cisplatin—testicular cancer	0.15	0.236	CbGbCtD
Triamcinolone—PTGS2—Etoposide—testicular cancer	0.147	0.232	CbGbCtD
Triamcinolone—CYP3A4—Ifosfamide—testicular cancer	0.0609	0.0961	CbGbCtD
Triamcinolone—CYP3A4—Vinblastine—testicular cancer	0.0323	0.051	CbGbCtD
Triamcinolone—CYP3A4—Etoposide—testicular cancer	0.0291	0.0459	CbGbCtD
Triamcinolone—CYP3A4—Doxorubicin—testicular cancer	0.0198	0.0313	CbGbCtD
Triamcinolone—Body temperature increased—Bleomycin—testicular cancer	0.000507	0.00138	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Doxorubicin—testicular cancer	0.000504	0.00138	CcSEcCtD
Triamcinolone—Dizziness—Vinblastine—testicular cancer	0.000502	0.00137	CcSEcCtD
Triamcinolone—Convulsion—Cisplatin—testicular cancer	0.000502	0.00137	CcSEcCtD
Triamcinolone—Mood swings—Methotrexate—testicular cancer	0.0005	0.00136	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.0005	0.00136	CcSEcCtD
Triamcinolone—Osteoarthritis—Epirubicin—testicular cancer	0.000494	0.00135	CcSEcCtD
Triamcinolone—Myalgia—Cisplatin—testicular cancer	0.000493	0.00135	CcSEcCtD
Triamcinolone—Feeling abnormal—Dactinomycin—testicular cancer	0.000493	0.00135	CcSEcCtD
Triamcinolone—Nausea—Chlorambucil—testicular cancer	0.000492	0.00134	CcSEcCtD
Triamcinolone—Paraesthesia—Ifosfamide—testicular cancer	0.000492	0.00134	CcSEcCtD
Triamcinolone—Ill-defined disorder—Etoposide—testicular cancer	0.000492	0.00134	CcSEcCtD
Triamcinolone—Dyspnoea—Ifosfamide—testicular cancer	0.000489	0.00133	CcSEcCtD
Triamcinolone—Discomfort—Cisplatin—testicular cancer	0.000487	0.00133	CcSEcCtD
Triamcinolone—Increased appetite—Doxorubicin—testicular cancer	0.000487	0.00133	CcSEcCtD
Triamcinolone—Affect lability—Epirubicin—testicular cancer	0.000486	0.00133	CcSEcCtD
Triamcinolone—Vomiting—Vinblastine—testicular cancer	0.000483	0.00132	CcSEcCtD
Triamcinolone—Malaise—Etoposide—testicular cancer	0.000479	0.00131	CcSEcCtD
Triamcinolone—Dermatitis bullous—Doxorubicin—testicular cancer	0.000478	0.00131	CcSEcCtD
Triamcinolone—Vertigo—Etoposide—testicular cancer	0.000477	0.0013	CcSEcCtD
Triamcinolone—Headache—Vinblastine—testicular cancer	0.000476	0.0013	CcSEcCtD
Triamcinolone—Purpura—Doxorubicin—testicular cancer	0.000474	0.00129	CcSEcCtD
Triamcinolone—Body temperature increased—Dactinomycin—testicular cancer	0.000473	0.00129	CcSEcCtD
Triamcinolone—Fatigue—Ifosfamide—testicular cancer	0.000473	0.00129	CcSEcCtD
Triamcinolone—Anaphylactic shock—Cisplatin—testicular cancer	0.000473	0.00129	CcSEcCtD
Triamcinolone—Oedema—Cisplatin—testicular cancer	0.000473	0.00129	CcSEcCtD
Triamcinolone—Hypersensitivity—Bleomycin—testicular cancer	0.000473	0.00129	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000472	0.00129	CcSEcCtD
Triamcinolone—Cardiac arrest—Epirubicin—testicular cancer	0.00047	0.00128	CcSEcCtD
Triamcinolone—Infection—Cisplatin—testicular cancer	0.00047	0.00128	CcSEcCtD
Triamcinolone—Pain—Ifosfamide—testicular cancer	0.000469	0.00128	CcSEcCtD
Triamcinolone—Mood swings—Epirubicin—testicular cancer	0.000468	0.00128	CcSEcCtD
Triamcinolone—Loss of consciousness—Etoposide—testicular cancer	0.000466	0.00127	CcSEcCtD
Triamcinolone—Cough—Etoposide—testicular cancer	0.000463	0.00126	CcSEcCtD
Triamcinolone—Tachycardia—Cisplatin—testicular cancer	0.000461	0.00126	CcSEcCtD
Triamcinolone—Asthenia—Bleomycin—testicular cancer	0.00046	0.00126	CcSEcCtD
Triamcinolone—Convulsion—Etoposide—testicular cancer	0.00046	0.00125	CcSEcCtD
Triamcinolone—Hypertension—Etoposide—testicular cancer	0.000458	0.00125	CcSEcCtD
Triamcinolone—Osteoarthritis—Doxorubicin—testicular cancer	0.000457	0.00125	CcSEcCtD
Triamcinolone—Hyperhidrosis—Cisplatin—testicular cancer	0.000457	0.00125	CcSEcCtD
Triamcinolone—Asthma—Methotrexate—testicular cancer	0.000456	0.00124	CcSEcCtD
Triamcinolone—Pruritus—Bleomycin—testicular cancer	0.000454	0.00124	CcSEcCtD
Triamcinolone—Feeling abnormal—Ifosfamide—testicular cancer	0.000452	0.00123	CcSEcCtD
Triamcinolone—Nausea—Vinblastine—testicular cancer	0.000451	0.00123	CcSEcCtD
Triamcinolone—Affect lability—Doxorubicin—testicular cancer	0.00045	0.00123	CcSEcCtD
Triamcinolone—Pancreatitis—Methotrexate—testicular cancer	0.000447	0.00122	CcSEcCtD
Triamcinolone—Discomfort—Etoposide—testicular cancer	0.000446	0.00122	CcSEcCtD
Triamcinolone—Hypersensitivity—Dactinomycin—testicular cancer	0.000441	0.0012	CcSEcCtD
Triamcinolone—Muscular weakness—Epirubicin—testicular cancer	0.000436	0.00119	CcSEcCtD
Triamcinolone—Urticaria—Ifosfamide—testicular cancer	0.000436	0.00119	CcSEcCtD
Triamcinolone—Cardiac arrest—Doxorubicin—testicular cancer	0.000435	0.00119	CcSEcCtD
Triamcinolone—Body temperature increased—Ifosfamide—testicular cancer	0.000434	0.00118	CcSEcCtD
Triamcinolone—Anaphylactic shock—Etoposide—testicular cancer	0.000433	0.00118	CcSEcCtD
Triamcinolone—Mood swings—Doxorubicin—testicular cancer	0.000433	0.00118	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000431	0.00118	CcSEcCtD
Triamcinolone—Infection—Etoposide—testicular cancer	0.00043	0.00117	CcSEcCtD
Triamcinolone—Abdominal distension—Epirubicin—testicular cancer	0.00043	0.00117	CcSEcCtD
Triamcinolone—Asthenia—Dactinomycin—testicular cancer	0.000429	0.00117	CcSEcCtD
Triamcinolone—Asthma—Epirubicin—testicular cancer	0.000427	0.00117	CcSEcCtD
Triamcinolone—Influenza—Epirubicin—testicular cancer	0.000427	0.00117	CcSEcCtD
Triamcinolone—Paraesthesia—Cisplatin—testicular cancer	0.000425	0.00116	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000424	0.00116	CcSEcCtD
Triamcinolone—Tachycardia—Etoposide—testicular cancer	0.000423	0.00115	CcSEcCtD
Triamcinolone—Dyspnoea—Cisplatin—testicular cancer	0.000422	0.00115	CcSEcCtD
Triamcinolone—Hyperhidrosis—Etoposide—testicular cancer	0.000419	0.00114	CcSEcCtD
Triamcinolone—Pancreatitis—Epirubicin—testicular cancer	0.000419	0.00114	CcSEcCtD
Triamcinolone—Bronchitis—Epirubicin—testicular cancer	0.000411	0.00112	CcSEcCtD
Triamcinolone—Vomiting—Bleomycin—testicular cancer	0.000408	0.00111	CcSEcCtD
Triamcinolone—Rash—Bleomycin—testicular cancer	0.000405	0.0011	CcSEcCtD
Triamcinolone—Pain—Cisplatin—testicular cancer	0.000404	0.0011	CcSEcCtD
Triamcinolone—Dermatitis—Bleomycin—testicular cancer	0.000404	0.0011	CcSEcCtD
Triamcinolone—Hypersensitivity—Ifosfamide—testicular cancer	0.000404	0.0011	CcSEcCtD
Triamcinolone—Muscular weakness—Doxorubicin—testicular cancer	0.000403	0.0011	CcSEcCtD
Triamcinolone—Abdominal distension—Doxorubicin—testicular cancer	0.000398	0.00109	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000397	0.00108	CcSEcCtD
Triamcinolone—Conjunctivitis—Methotrexate—testicular cancer	0.000395	0.00108	CcSEcCtD
Triamcinolone—Asthma—Doxorubicin—testicular cancer	0.000395	0.00108	CcSEcCtD
Triamcinolone—Influenza—Doxorubicin—testicular cancer	0.000395	0.00108	CcSEcCtD
Triamcinolone—Asthenia—Ifosfamide—testicular cancer	0.000393	0.00107	CcSEcCtD
Triamcinolone—Feeling abnormal—Cisplatin—testicular cancer	0.00039	0.00106	CcSEcCtD
Triamcinolone—Paraesthesia—Etoposide—testicular cancer	0.000389	0.00106	CcSEcCtD
Triamcinolone—Weight increased—Epirubicin—testicular cancer	0.000389	0.00106	CcSEcCtD
Triamcinolone—Pruritus—Ifosfamide—testicular cancer	0.000388	0.00106	CcSEcCtD
Triamcinolone—Pancreatitis—Doxorubicin—testicular cancer	0.000387	0.00106	CcSEcCtD
Triamcinolone—Dyspnoea—Etoposide—testicular cancer	0.000386	0.00105	CcSEcCtD
Triamcinolone—Epistaxis—Methotrexate—testicular cancer	0.000384	0.00105	CcSEcCtD
Triamcinolone—Nausea—Bleomycin—testicular cancer	0.000381	0.00104	CcSEcCtD
Triamcinolone—Vomiting—Dactinomycin—testicular cancer	0.000381	0.00104	CcSEcCtD
Triamcinolone—Bronchitis—Doxorubicin—testicular cancer	0.00038	0.00104	CcSEcCtD
Triamcinolone—Rash—Dactinomycin—testicular cancer	0.000377	0.00103	CcSEcCtD
Triamcinolone—Body temperature increased—Cisplatin—testicular cancer	0.000374	0.00102	CcSEcCtD
Triamcinolone—Fatigue—Etoposide—testicular cancer	0.000373	0.00102	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Epirubicin—testicular cancer	0.000373	0.00102	CcSEcCtD
Triamcinolone—Pain—Etoposide—testicular cancer	0.00037	0.00101	CcSEcCtD
Triamcinolone—Conjunctivitis—Epirubicin—testicular cancer	0.00037	0.00101	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000367	0.001	CcSEcCtD
Triamcinolone—Haemoglobin—Methotrexate—testicular cancer	0.000367	0.001	CcSEcCtD
Triamcinolone—Haemorrhage—Methotrexate—testicular cancer	0.000365	0.000996	CcSEcCtD
Triamcinolone—Dizziness—Ifosfamide—testicular cancer	0.000363	0.00099	CcSEcCtD
Triamcinolone—Pharyngitis—Methotrexate—testicular cancer	0.000362	0.000989	CcSEcCtD
Triamcinolone—Weight increased—Doxorubicin—testicular cancer	0.00036	0.000981	CcSEcCtD
Triamcinolone—Epistaxis—Epirubicin—testicular cancer	0.000359	0.00098	CcSEcCtD
Triamcinolone—Feeling abnormal—Etoposide—testicular cancer	0.000357	0.000974	CcSEcCtD
Triamcinolone—Nausea—Dactinomycin—testicular cancer	0.000355	0.00097	CcSEcCtD
Triamcinolone—Vomiting—Ifosfamide—testicular cancer	0.000349	0.000951	CcSEcCtD
Triamcinolone—Hypersensitivity—Cisplatin—testicular cancer	0.000348	0.000951	CcSEcCtD
Triamcinolone—Bradycardia—Epirubicin—testicular cancer	0.000348	0.000949	CcSEcCtD
Triamcinolone—Rash—Ifosfamide—testicular cancer	0.000346	0.000944	CcSEcCtD
Triamcinolone—Dermatitis—Ifosfamide—testicular cancer	0.000345	0.000943	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000345	0.000942	CcSEcCtD
Triamcinolone—Urticaria—Etoposide—testicular cancer	0.000344	0.000939	CcSEcCtD
Triamcinolone—Haemoglobin—Epirubicin—testicular cancer	0.000343	0.000937	CcSEcCtD
Triamcinolone—Rhinitis—Epirubicin—testicular cancer	0.000343	0.000935	CcSEcCtD
Triamcinolone—Body temperature increased—Etoposide—testicular cancer	0.000342	0.000934	CcSEcCtD
Triamcinolone—Conjunctivitis—Doxorubicin—testicular cancer	0.000342	0.000934	CcSEcCtD
Triamcinolone—Haemorrhage—Epirubicin—testicular cancer	0.000342	0.000933	CcSEcCtD
Triamcinolone—Asthenia—Cisplatin—testicular cancer	0.000339	0.000926	CcSEcCtD
Triamcinolone—Pharyngitis—Epirubicin—testicular cancer	0.000339	0.000926	CcSEcCtD
Triamcinolone—Epistaxis—Doxorubicin—testicular cancer	0.000332	0.000907	CcSEcCtD
Triamcinolone—Nausea—Ifosfamide—testicular cancer	0.000326	0.000889	CcSEcCtD
Triamcinolone—Bradycardia—Doxorubicin—testicular cancer	0.000322	0.000878	CcSEcCtD
Triamcinolone—Hypersensitivity—Etoposide—testicular cancer	0.000319	0.000871	CcSEcCtD
Triamcinolone—Erythema—Methotrexate—testicular cancer	0.000318	0.000867	CcSEcCtD
Triamcinolone—Haemoglobin—Doxorubicin—testicular cancer	0.000318	0.000867	CcSEcCtD
Triamcinolone—Rhinitis—Doxorubicin—testicular cancer	0.000317	0.000865	CcSEcCtD
Triamcinolone—Haemorrhage—Doxorubicin—testicular cancer	0.000316	0.000863	CcSEcCtD
Triamcinolone—Pharyngitis—Doxorubicin—testicular cancer	0.000314	0.000856	CcSEcCtD
Triamcinolone—Dysgeusia—Methotrexate—testicular cancer	0.000311	0.000849	CcSEcCtD
Triamcinolone—Asthenia—Etoposide—testicular cancer	0.000311	0.000848	CcSEcCtD
Triamcinolone—Back pain—Methotrexate—testicular cancer	0.000308	0.000839	CcSEcCtD
Triamcinolone—Pruritus—Etoposide—testicular cancer	0.000306	0.000836	CcSEcCtD
Triamcinolone—Arrhythmia—Epirubicin—testicular cancer	0.000305	0.000833	CcSEcCtD
Triamcinolone—Vomiting—Cisplatin—testicular cancer	0.000301	0.00082	CcSEcCtD
Triamcinolone—Rash—Cisplatin—testicular cancer	0.000298	0.000813	CcSEcCtD
Triamcinolone—Dermatitis—Cisplatin—testicular cancer	0.000298	0.000813	CcSEcCtD
Triamcinolone—Erythema—Epirubicin—testicular cancer	0.000298	0.000812	CcSEcCtD
Triamcinolone—Ill-defined disorder—Methotrexate—testicular cancer	0.000295	0.000805	CcSEcCtD
Triamcinolone—Dysgeusia—Epirubicin—testicular cancer	0.000291	0.000795	CcSEcCtD
Triamcinolone—Back pain—Epirubicin—testicular cancer	0.000288	0.000785	CcSEcCtD
Triamcinolone—Malaise—Methotrexate—testicular cancer	0.000287	0.000782	CcSEcCtD
Triamcinolone—Dizziness—Etoposide—testicular cancer	0.000286	0.000782	CcSEcCtD
Triamcinolone—Vertigo—Methotrexate—testicular cancer	0.000286	0.000779	CcSEcCtD
Triamcinolone—Arrhythmia—Doxorubicin—testicular cancer	0.000282	0.000771	CcSEcCtD
Triamcinolone—Nausea—Cisplatin—testicular cancer	0.000281	0.000766	CcSEcCtD
Triamcinolone—Cough—Methotrexate—testicular cancer	0.000277	0.000757	CcSEcCtD
Triamcinolone—Ill-defined disorder—Epirubicin—testicular cancer	0.000276	0.000753	CcSEcCtD
Triamcinolone—Convulsion—Methotrexate—testicular cancer	0.000275	0.000752	CcSEcCtD
Triamcinolone—Vomiting—Etoposide—testicular cancer	0.000275	0.000751	CcSEcCtD
Triamcinolone—Erythema—Doxorubicin—testicular cancer	0.000275	0.000751	CcSEcCtD
Triamcinolone—Rash—Etoposide—testicular cancer	0.000273	0.000745	CcSEcCtD
Triamcinolone—Dermatitis—Etoposide—testicular cancer	0.000273	0.000745	CcSEcCtD
Triamcinolone—Headache—Etoposide—testicular cancer	0.000271	0.00074	CcSEcCtD
Triamcinolone—Myalgia—Methotrexate—testicular cancer	0.000271	0.000739	CcSEcCtD
Triamcinolone—Dysgeusia—Doxorubicin—testicular cancer	0.00027	0.000736	CcSEcCtD
Triamcinolone—Malaise—Epirubicin—testicular cancer	0.000268	0.000732	CcSEcCtD
Triamcinolone—Discomfort—Methotrexate—testicular cancer	0.000267	0.00073	CcSEcCtD
Triamcinolone—Vertigo—Epirubicin—testicular cancer	0.000267	0.000729	CcSEcCtD
Triamcinolone—Syncope—Epirubicin—testicular cancer	0.000267	0.000728	CcSEcCtD
Triamcinolone—Back pain—Doxorubicin—testicular cancer	0.000266	0.000727	CcSEcCtD
Triamcinolone—Loss of consciousness—Epirubicin—testicular cancer	0.000261	0.000713	CcSEcCtD
Triamcinolone—Cough—Epirubicin—testicular cancer	0.00026	0.000708	CcSEcCtD
Triamcinolone—Anaphylactic shock—Methotrexate—testicular cancer	0.000259	0.000708	CcSEcCtD
Triamcinolone—Convulsion—Epirubicin—testicular cancer	0.000258	0.000703	CcSEcCtD
Triamcinolone—Infection—Methotrexate—testicular cancer	0.000258	0.000703	CcSEcCtD
Triamcinolone—Nausea—Etoposide—testicular cancer	0.000257	0.000702	CcSEcCtD
Triamcinolone—Hypertension—Epirubicin—testicular cancer	0.000257	0.000701	CcSEcCtD
Triamcinolone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000255	0.000697	CcSEcCtD
Triamcinolone—Myalgia—Epirubicin—testicular cancer	0.000253	0.000691	CcSEcCtD
Triamcinolone—Hyperhidrosis—Methotrexate—testicular cancer	0.000251	0.000684	CcSEcCtD
Triamcinolone—Discomfort—Epirubicin—testicular cancer	0.00025	0.000683	CcSEcCtD
Triamcinolone—Malaise—Doxorubicin—testicular cancer	0.000248	0.000677	CcSEcCtD
Triamcinolone—Dry mouth—Epirubicin—testicular cancer	0.000248	0.000676	CcSEcCtD
Triamcinolone—Vertigo—Doxorubicin—testicular cancer	0.000247	0.000675	CcSEcCtD
Triamcinolone—Syncope—Doxorubicin—testicular cancer	0.000247	0.000674	CcSEcCtD
Triamcinolone—Anaphylactic shock—Epirubicin—testicular cancer	0.000243	0.000663	CcSEcCtD
Triamcinolone—Oedema—Epirubicin—testicular cancer	0.000243	0.000663	CcSEcCtD
Triamcinolone—Loss of consciousness—Doxorubicin—testicular cancer	0.000242	0.00066	CcSEcCtD
Triamcinolone—Infection—Epirubicin—testicular cancer	0.000241	0.000658	CcSEcCtD
Triamcinolone—Cough—Doxorubicin—testicular cancer	0.00024	0.000655	CcSEcCtD
Triamcinolone—Shock—Epirubicin—testicular cancer	0.000239	0.000652	CcSEcCtD
Triamcinolone—Convulsion—Doxorubicin—testicular cancer	0.000239	0.000651	CcSEcCtD
Triamcinolone—Hypertension—Doxorubicin—testicular cancer	0.000238	0.000648	CcSEcCtD
Triamcinolone—Tachycardia—Epirubicin—testicular cancer	0.000237	0.000647	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000236	0.000645	CcSEcCtD
Triamcinolone—Hyperhidrosis—Epirubicin—testicular cancer	0.000235	0.00064	CcSEcCtD
Triamcinolone—Insomnia—Methotrexate—testicular cancer	0.000235	0.00064	CcSEcCtD
Triamcinolone—Myalgia—Doxorubicin—testicular cancer	0.000234	0.000639	CcSEcCtD
Triamcinolone—Paraesthesia—Methotrexate—testicular cancer	0.000233	0.000636	CcSEcCtD
Triamcinolone—Discomfort—Doxorubicin—testicular cancer	0.000232	0.000632	CcSEcCtD
Triamcinolone—Dyspnoea—Methotrexate—testicular cancer	0.000231	0.000631	CcSEcCtD
Triamcinolone—Dry mouth—Doxorubicin—testicular cancer	0.000229	0.000625	CcSEcCtD
Triamcinolone—Dyspepsia—Methotrexate—testicular cancer	0.000228	0.000623	CcSEcCtD
Triamcinolone—Oedema—Doxorubicin—testicular cancer	0.000225	0.000613	CcSEcCtD
Triamcinolone—Anaphylactic shock—Doxorubicin—testicular cancer	0.000225	0.000613	CcSEcCtD
Triamcinolone—Fatigue—Methotrexate—testicular cancer	0.000224	0.00061	CcSEcCtD
Triamcinolone—Infection—Doxorubicin—testicular cancer	0.000223	0.000609	CcSEcCtD
Triamcinolone—Pain—Methotrexate—testicular cancer	0.000222	0.000605	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000221	0.000604	CcSEcCtD
Triamcinolone—Shock—Doxorubicin—testicular cancer	0.000221	0.000603	CcSEcCtD
Triamcinolone—Insomnia—Epirubicin—testicular cancer	0.00022	0.000599	CcSEcCtD
Triamcinolone—Tachycardia—Doxorubicin—testicular cancer	0.000219	0.000598	CcSEcCtD
Triamcinolone—Paraesthesia—Epirubicin—testicular cancer	0.000218	0.000595	CcSEcCtD
Triamcinolone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000217	0.000593	CcSEcCtD
Triamcinolone—Dyspnoea—Epirubicin—testicular cancer	0.000216	0.000591	CcSEcCtD
Triamcinolone—Feeling abnormal—Methotrexate—testicular cancer	0.000214	0.000583	CcSEcCtD
Triamcinolone—Dyspepsia—Epirubicin—testicular cancer	0.000214	0.000583	CcSEcCtD
Triamcinolone—Fatigue—Epirubicin—testicular cancer	0.000209	0.000571	CcSEcCtD
Triamcinolone—Pain—Epirubicin—testicular cancer	0.000208	0.000567	CcSEcCtD
Triamcinolone—Urticaria—Methotrexate—testicular cancer	0.000206	0.000562	CcSEcCtD
Triamcinolone—Body temperature increased—Methotrexate—testicular cancer	0.000205	0.00056	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000205	0.000559	CcSEcCtD
Triamcinolone—Insomnia—Doxorubicin—testicular cancer	0.000203	0.000554	CcSEcCtD
Triamcinolone—Paraesthesia—Doxorubicin—testicular cancer	0.000202	0.00055	CcSEcCtD
Triamcinolone—Dyspnoea—Doxorubicin—testicular cancer	0.0002	0.000547	CcSEcCtD
Triamcinolone—Feeling abnormal—Epirubicin—testicular cancer	0.0002	0.000546	CcSEcCtD
Triamcinolone—Dyspepsia—Doxorubicin—testicular cancer	0.000198	0.00054	CcSEcCtD
Triamcinolone—Fatigue—Doxorubicin—testicular cancer	0.000194	0.000529	CcSEcCtD
Triamcinolone—Urticaria—Epirubicin—testicular cancer	0.000193	0.000526	CcSEcCtD
Triamcinolone—Pain—Doxorubicin—testicular cancer	0.000192	0.000524	CcSEcCtD
Triamcinolone—Body temperature increased—Epirubicin—testicular cancer	0.000192	0.000524	CcSEcCtD
Triamcinolone—Hypersensitivity—Methotrexate—testicular cancer	0.000191	0.000522	CcSEcCtD
Triamcinolone—Asthenia—Methotrexate—testicular cancer	0.000186	0.000508	CcSEcCtD
Triamcinolone—Feeling abnormal—Doxorubicin—testicular cancer	0.000185	0.000505	CcSEcCtD
Triamcinolone—Pruritus—Methotrexate—testicular cancer	0.000184	0.000501	CcSEcCtD
Triamcinolone—Hypersensitivity—Epirubicin—testicular cancer	0.000179	0.000488	CcSEcCtD
Triamcinolone—Urticaria—Doxorubicin—testicular cancer	0.000178	0.000487	CcSEcCtD
Triamcinolone—Body temperature increased—Doxorubicin—testicular cancer	0.000178	0.000485	CcSEcCtD
Triamcinolone—Asthenia—Epirubicin—testicular cancer	0.000174	0.000475	CcSEcCtD
Triamcinolone—Pruritus—Epirubicin—testicular cancer	0.000172	0.000469	CcSEcCtD
Triamcinolone—Dizziness—Methotrexate—testicular cancer	0.000172	0.000468	CcSEcCtD
Triamcinolone—Hypersensitivity—Doxorubicin—testicular cancer	0.000166	0.000452	CcSEcCtD
Triamcinolone—Vomiting—Methotrexate—testicular cancer	0.000165	0.00045	CcSEcCtD
Triamcinolone—Rash—Methotrexate—testicular cancer	0.000164	0.000446	CcSEcCtD
Triamcinolone—Dermatitis—Methotrexate—testicular cancer	0.000163	0.000446	CcSEcCtD
Triamcinolone—Headache—Methotrexate—testicular cancer	0.000163	0.000444	CcSEcCtD
Triamcinolone—Asthenia—Doxorubicin—testicular cancer	0.000161	0.00044	CcSEcCtD
Triamcinolone—Dizziness—Epirubicin—testicular cancer	0.000161	0.000438	CcSEcCtD
Triamcinolone—Pruritus—Doxorubicin—testicular cancer	0.000159	0.000434	CcSEcCtD
Triamcinolone—Vomiting—Epirubicin—testicular cancer	0.000154	0.000421	CcSEcCtD
Triamcinolone—Nausea—Methotrexate—testicular cancer	0.000154	0.000421	CcSEcCtD
Triamcinolone—Rash—Epirubicin—testicular cancer	0.000153	0.000418	CcSEcCtD
Triamcinolone—Dermatitis—Epirubicin—testicular cancer	0.000153	0.000417	CcSEcCtD
Triamcinolone—Headache—Epirubicin—testicular cancer	0.000152	0.000415	CcSEcCtD
Triamcinolone—Dizziness—Doxorubicin—testicular cancer	0.000149	0.000405	CcSEcCtD
Triamcinolone—Nausea—Epirubicin—testicular cancer	0.000144	0.000394	CcSEcCtD
Triamcinolone—Vomiting—Doxorubicin—testicular cancer	0.000143	0.00039	CcSEcCtD
Triamcinolone—Rash—Doxorubicin—testicular cancer	0.000142	0.000387	CcSEcCtD
Triamcinolone—Dermatitis—Doxorubicin—testicular cancer	0.000142	0.000386	CcSEcCtD
Triamcinolone—Headache—Doxorubicin—testicular cancer	0.000141	0.000384	CcSEcCtD
Triamcinolone—Nausea—Doxorubicin—testicular cancer	0.000133	0.000364	CcSEcCtD
